Skip to Main Content

Donald Trump

STAT coverage of Donald Trump policies on health and science, and what a second Trump Administration has meant for federal regulatory agencies, scientific research, drug development and health care delivery.

Latest

Health Associated Press

Experts wonder ‘Where is the CDC?’ as hantavirus outbreak unfolds

Politics Lizzy Lawrence

Trump reportedly plans to fire FDA Commissioner Makary

Special Report Andrew Joseph

Immigration changes are driving foreign researchers to leave the U.S. — or not come to begin with

Health Elizabeth Cooney, Chelsea Cirruzzo, and Daniel Payne

Trump drops Casey Means as surgeon general nominee, opts for radiologist Nicole Saphier

Special Report Anil Oza

Securing NIH awards is getting more competitive — and confusing

Politics O. Rose Broderick

In first meeting, federal autism committee focuses on ‘profound autism’

Biotech Daniel Payne

STAT Plus: Trump celebrates closing first round of drug pricing deals, promises more ahead

Politics Associated Press

Trump reclassifies state-licensed medical marijuana as a less-dangerous drug in a historic shift

All Coverage

D.C. Diagnosis John Wilkerson

STAT Plus: RFK Jr. to face four GOP doctors at Senate hearings

Politics Elaine Chen

STAT Plus: Trump order to advance psychedelic treatments generates excitement — and worries

Advertisement

First Opinion Ross Ellenhorn and Dimitri Mugianis

The contradiction at the heart of Republicans’ embrace of psychedelics

Politics Helen Branswell, Daniel Payne, and Chelsea Cirruzzo

Optimism for Trump’s CDC pick is tempered by questions about RFK Jr.’s role

Politics Chelsea Cirruzzo

STAT Plus: 7 key issues we’re watching as RFK Jr. faces a Congressional gauntlet

Politics Megan Molteni

STAT Plus: Trump administration drops court fight to cap NIH payments for research overhead costs

D.C. Diagnosis John Wilkerson

STAT Plus: Trump budget’s ‘America First’ drug policy proposals

Politics Megan Molteni and Anil Oza

STAT Plus: NIH would get $5 billion cut under Trump’s 2027 budget, but Congress unlikely to go along

Health Chelsea Cirruzzo and John Wilkerson

STAT Plus: White House proposes 12% cut to federal health agencies in 2027 budget request

Exclusive Daniel Payne

STAT Plus: Small drugmakers, facing threat of tariffs, negotiate pricing deals with White House

Biotech Daniel Payne

STAT Plus: Trump announces 100% tariffs on brand-name drugs, with plenty of carveouts

Biotech Daniel Payne

STAT Plus: Trump administration prepares 100% tariffs on some imported drugs

Politics Anil Oza

STAT Plus: NIH director’s invocation of Vannevar Bush’s legacy to promote Trump science policies sparks pushback

Exclusive John Wilkerson

STAT Plus: HSA companies struck it big in Trump’s tax bill. They’re lobbying for more

Exclusive Daniel Payne

STAT Plus: In private meetings, White House works to win pharma companies’ support for drug pricing bill

Special Report Megan Molteni, Anil Oza, and Jonathan Wosen

NIH restrictions on foreign research partnerships significantly impacted 1 in 4 U.S. scientists

Health Anil Oza

As political pressure mounts, medical school accreditor drops requirement to teach about health equity

Health Helen Branswell

STAT Plus: CDC leadership in limbo as Trump administration set to miss deadline to nominate director

Special Report Jonathan Wosen

National survey of NIH-funded researchers shows precarious state of U.S. science — ‘This is like the Titanic’

Politics O. Rose Broderick

As Trump administration cracks down on health care fraud, people with disabilities feel singled out

Politics John Wilkerson

STAT Plus: Trump is getting more credit than Biden for efforts to lower drug prices